|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/11 | |
| C12N 15/113 | |||
| A61K 31/712 |
| (11) | Patento numeris | 1910395 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06773838.5 |
| Europos patento paraiškos padavimo data | 2006-06-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-04-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-10-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2006/024469 |
| Data | 2006-06-23 |
| (87) | Numeris | WO 2007/002390 |
| Data | 2007-01-04 |
| (30) | Numeris | Data | Šalis |
| 693542 P | 2005-06-23 | US |
| (72) |
BAKER, Brenda, F., US
KRAINER, Adrian, R., US
HUA, Yimin, US
|
| (73) |
Isis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
COLD SPRING HARBOR LABORATORY, Box 100, One Bungtown Road, Cold Spring Harbor, NY 11724, US |
| (54) | Compositions and methods for modulation of SMN2 splicing |
| Compositions and methods for modulation of SMN2 splicing |